BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6296350)

  • 1. The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo.
    Kudo Y; Sokabe H
    J Pharmacobiodyn; 1982 Sep; 5(9):745-7. PubMed ID: 6296350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors.
    Singh BN; Nisbet HE; Harris EA; Whitlock RM
    Eur J Pharmacol; 1975 Nov; 34(1):75-86. PubMed ID: 11998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
    Kudo Y; Sokabe H; Zehr JE
    J Pharmacobiodyn; 1981 Jul; 4(7):475-82. PubMed ID: 6117611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic propranolol treatment decreases cardiac beta-adrenoceptors in spontaneously hypertensive rats.
    Baker SP; Katovich MJ
    Eur J Pharmacol; 1982 Mar; 78(4):479-82. PubMed ID: 6281038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic treatments with atenolol and propranolol on cardiovascular responses to handling stress in spontaneously hypertensive rats.
    Kudo Y; Sokabe H; Kawashima K
    J Pharmacobiodyn; 1983 Oct; 6(10):729-36. PubMed ID: 6141234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
    Pringle TH; Riddell JG; Shanks RG
    Eur J Clin Pharmacol; 1988; 35(5):507-14. PubMed ID: 2853055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atenolol, metroprolol, and pamatolol on cardiac and vascular beta-adrenoceptors in the rat.
    Johansson B
    J Cardiovasc Pharmacol; 1979; 1(3):287-98. PubMed ID: 94397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.
    Himori N; Honma S; Izumi A; Ishimori T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Feb; 316(1):19-23. PubMed ID: 6116195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 1 - beta 2 blocking activity of propranolol and metoprolol in the unanaesthetized genetically hypertensive and normotensive rat.
    Luca C; Marchini F; Usardi MM
    Pharmacol Res Commun; 1984 Apr; 16(4):359-68. PubMed ID: 6328546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).
    Bilski AJ; Halliday SE; Fitzgerald JD; Wale JL
    J Cardiovasc Pharmacol; 1983; 5(3):430-7. PubMed ID: 6191142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation.
    Osborn JL; DiBona GF; Thames MD
    J Pharmacol Exp Ther; 1981 Feb; 216(2):265-9. PubMed ID: 6257884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.